Prostate and genitourinary cancers multidisciplinary team
The Urologic Tumor Center team at VCU Massey Cancer Center consists of national leaders in cancer care and research from multiple disciplines who work together to provide the highest-quality diagnosis and treatment of prostate and other genitourinary tumors. By pooling their expertise, our doctors are able to make the best decisions and give the most comprehensive advice and information. The Urologic Tumor Center includes three urologists:
- Mayer Grob, M.D., a urologist specializing in genitourinary cancers
- George Guruli, M.D., Ph.D., a physician-researcher who focuses on the mechanisms of prostate cancer and immune cells
- Lance Hampton, M.D., a urologist specializing in minimally invasive, laparoscopic and robotic techniques
- Asit Paul, M.D., Ph.D., a medical oncologist specializing in genitourinary cancers
- Alfredo Urdaneta, M.D., a radiation oncologist specializing in prostate and genitourinary cancers
- John Quillin, Ph.D., M.P.H., C.G.C., genetic counselor
VCU Massey Cancer Center pioneered the concept of multidisciplinary teams, a practice in which multiple genito-urinary cancer specialists meet regularly to evaluate, discuss and plan treatments for patients. This approach means that patients can get all of their treatments at the same place from professionals who work together and communicate regularly, rather than putting the burden on patients to coordinate communication among various doctors throughout the region. This is a significant and important advantage of receiving care at a comprehensive academic medical center.
- Multi-specialty consultation in one place at one time
- Rapid diagnosis and evaluation for early detection of cancers
- New forms of surgical treatment, including da Vinci robotic surgery, that preserve the function of organs
- State-of-the-art treatment options in radiotherapy and chemotherapy
- Opportunity to enroll in clinical trials of new and promising forms of treatment
- Advanced noninvasive tumor staging to design the most appropriate treatments
- Evaluation for tumor recurrences and the need for continued therapy
- Risk evaluation
The Urologic Tumor Center has increased its capacity to treat cancers of the urinary system with the addition of a state-of-the-art da Vinci Surgical System. Dr. Hampton, director of robotic urology and an assistant professor of surgery, answers questions about the new da Vinci robotic system.
What procedures are being performed using the da Vinci system?
I perform several different operations for both benign and malignant disease of the bladder, prostate and kidney. I, along with our robotic surgery team, have performed countless radical prostatectomy operations for prostate cancer, and nephrectomies for both benign and malignant conditions of the kidney. Our number of cases continues to increase, and we are typically utilizing the robot several times a week.
What are some advantages of the da Vinci system?
The da Vinci robot has multiple advantages for urologic surgery. Because of the magnified 3-D vision, I am able to perform complex nerve-sparing prostatectomies, which will cure the patient of prostate cancer and preserve his quality of life, maintaining erections and continence. During kidney surgery, the robot system allows me to fully appreciate the intricate 3-D spatial relationships of large blood vessels around the kidney in order to minimize blood loss.
The Urologic Tumor Center is located at Massey’s flagship location on the MCV Campus just off Exit 74C of I-95 in downtown Richmond. Free valet parking is available for your convenience. If there is anything we can do to make visiting the Center easier for you, please do not hesitate to ask.
The Urologic Tumor Center team believes in patient involvement. We encourage you to ask any and all questions you may have. Here are some of the questions we hear most frequently:
What is different about the Urologic Tumor Center and why should I go there?
The Urologic Tumor Center is the only comprehensive diagnostic and treatment center for urologic tumors in the Richmond area. It is staffed by leading specialists who also conduct research that leads to improved treatments for urologic cancers. Many of these treatments are only available at major academic medical centers like the VCU Medical Center. You will find it convenient to be evaluated by a group of closely collaborating specialists in one place at one time rather than having to go to a number of specialists at different locations. By pooling their experience and working together, doctors can make the best decisions regarding diagnosis and treatment and give you the most comprehensive advice and information.
Who should come to the Urologic Tumor Center?
Patients with a suspected or diagnosed urologic cancer may come for evaluation and treatment. Many patients come to the Center for a second opinion. Since specialists at the Center are on the leading edge in diagnosis and treatment, you will know that you have explored the best available options wherever you may decide to go for treatment.
How will the Urologic Tumor Center help me?
Doctors and nurses will examine you for possible disease using the latest diagnostic techniques.
How soon will I know the results of these tests?
In some cases, recommendations can be made during your first visit. If additional diagnostic testing is necessary, the physician or nurse will call you as soon as all of the results are available and will explain their meaning to you.
Which specialists will I see?
Depending on your condition, you are likely to see a medical oncologist, a surgical oncologist and a radiation oncologist who will all evaluate you from their perspective for the best possible treatment.
Will I be able to decide which treatment I will have if there are different options?
Absolutely. If a treatment plan is necessary, all steps and options will be clearly explained to you. The doctors and nurses at the Center will make sure you have all the information you need and help you make an informed decision.
- Find clinical trials for prostate and genitourinary cancers.
- Learn more about prostate and genitourinary cancers.